HopeStage
Back to all studies
Active Not RecruitingNCT07292233

A Food Effect Study of LY03020 in Healthy Subjects

Medication studyAges 18–45ChinaSchizophrenia
The study in practice

Understand this study

Who could participate?

This study is for healthy volunteers. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Listed locations
BeijingSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 30, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
16
Sponsor
Luye Pharma Group Ltd.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
China
Age range
From 18 Years to 45 Years
Official registry ID
NCT07292233
Official title
Show the full official title

A Randomized, Open-Label, Single-Dose, Two-Period, Crossover Phase I Clinical Study to Evaluate the Food Effect on the Pharmacokinetics of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Healthy Subjects

Recruitment & locations

Not recruiting

Beijing

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Luye Pharma Group Ltd., a pharmaceutical company.

Does this study involve medication?

Yes. The study involves medication, including LY03020.

Who can participate?

This study is for healthy volunteers. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies